How can biopharma companies and patient groups become true partners?

New Australian research launched today has shed light on how patient advocacy groups and communities want to interact with biopharma organisations.

Ann Single, coordinator and advisory committee member at Patient Voice Initiative (PVI) and Dr Simon Fifer, Director of Research and Innovation from CaPPRe joined Health Industry Hub to share the qualitative and patient preference study results which highlight how patient organisations, online communities and advocates want to interact with biopharma, including the domains that matter, how much they matter and satisfaction with current interactions.

This benchmarking research was designed to support a culture of patient involvement and further development of interactions based on an understanding of what patient groups and communities want.

Patient Voice Initiative would like to acknowledge CaPPRE’s time and expertise given in-kind to this research.

You may also register for the ARCS Consumer Partnership webinar on Tuesday 25 October, 12:30-1.30 pm AEDT.